ArticlePediatric health, medicine and therapeutics2025
Acute Fibrinous and Organizing Pneumonia (AFOP) in Children: A Case Report and Literature Review.
Article in Pediatric health, medicine and therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute Fibrinous and Organizing Pneumonia (AFOP) is a rare lung disease that presents with acute lung injury characterized by intra-alveolar fibrin deposition. Although primarily described in adults, AFOP can occur in children and may mimic common respiratory illnesses, posing a diagnostic challenge. The condition can result from various etiological factors, including infections, autoimmune disorders, and drug reactions. The purpose of this case is to highlight the clinical presentation, diagnostic challenges and management strategies of this rare and underrecognized pediatric condition. By describing this case we aim to raise awareness among pediatricians given the limited literature on pediatric AFOP to aid in recognizing and tailoring treatment in order to improve outcomes. Methods and Materials: Patient's data were collected retrospectively from medical records, including clinical notes, laboratory results, imaging studies, and histopathological findings, where applicable. Informed written consent was obtained and signed from parents of the child for the use of his medical information for educational and publication purposes, ensuring confidentiality and anonymity. Results: We present the case of a 3-year-old boy with a history of recurrent viral-induced wheezing, initially treated for asthma-like symptoms until he developed persistent hypoxemia. Despite targeted therapy, the patient exhibited persistent respiratory symptoms and consolidative opacities in the right lung. A high-resolution computed tomography (HRCT) scan showed diffuse lung abnormalities, prompting further evaluation. Bronchoscopy with bronchoalveolar lavage revealed Haemophilus influenzae infection, and an open lung biopsy confirmed AFOP. The patient was treated with corticosteroids and azithromycin, leading to significant clinical and radiographic improvement. Conclusion: This case highlights the importance of considering AFOP in pediatric patients with atypical and persistent respiratory symptoms. Early diagnosis and intervention are crucial for managing this rare condition. Further case reports are needed to better understand AFOP's clinical course and optimize treatment strategies in pediatric populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.